Literature DB >> 11063075

Future directions and emerging issues in technology transfer between HIV prevention researchers and community-based service providers.

J A Kelly1, E D Sogolow, M S Neumann.   

Abstract

The public health objective of preventing new HIV infections can be achieved only through effective information exchange among service providers, researchers, and policymakers. The potential for successful transfer of research-based HIV prevention technology to service providers will be enhanced if investigators take into account in the research planning stage how interventions will be used in the field, seek early input from community members and service providers, test variations of interventions that may increase their practicality in applied settings, and determine the cost and effectiveness of intervention delivery. Strategies are needed to ensure that the experiences of service providers help to inform the HIV prevention research agenda, improve service organization infrastructure and capacity development, and facilitate organizational networking so that providers can use new-generation HIV prevention interventions. Policies are needed to facilitate the development of intervention packages, training, and ongoing technical assistance for service providers in implementing effective HIV prevention interventions.

Entities:  

Mesh:

Year:  2000        PMID: 11063075

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  10 in total

Review 1.  Computer technology-based interventions in HIV prevention: state of the evidence and future directions for research.

Authors:  Seth M Noar
Journal:  AIDS Care       Date:  2011-05

2.  Common processes in evidence-based adolescent HIV prevention programs.

Authors:  Barbara L Ingram; Diane Flannery; Amy Elkavich; Mary Jane Rotheram-Borus
Journal:  AIDS Behav       Date:  2008-03-11

3.  Defining, designing, implementing, and evaluating phase 4 HIV prevention effectiveness trials for vulnerable populations.

Authors:  Jeffrey A Kelly; Freya Spielberg; Timothy L McAuliffe
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

4.  The Global HIV Archive: Facilitating the Transition from Science to Practice of Efficacious HIV Prevention Interventions.

Authors:  Josefina J Card; Emily N Newman; Rachel E Golden; Tamara Kuhn; Carmela Lomonaco
Journal:  World J AIDS       Date:  2013-03

5.  Tailoring evidence-based interventions for new populations: a method for program adaptation through community engagement.

Authors:  Emily K Chen; M C Reid; Samantha J Parker; Karl Pillemer
Journal:  Eval Health Prof       Date:  2012-04-19       Impact factor: 2.651

6.  Common principles embedded in effective adolescent HIV prevention programs.

Authors:  Mary Jane Rotheram-Borus; Barbara L Ingram; Dallas Swendeman; Diane Flannery
Journal:  AIDS Behav       Date:  2009-02-18

7.  Modeling the Structure of Partnership Between Researchers and Front-Line Service Providers: Strengthening Collaborative Public Health Research.

Authors:  Rogério M Pinto; Melanie M Wall; Anya Y Spector
Journal:  J Mix Methods Res       Date:  2014-01-01

8.  An exploratory study to examine intentions to adopt an evidence-based HIV linkage-to-care intervention among state health department AIDS directors in the United States.

Authors:  Wynne E Norton
Journal:  Implement Sci       Date:  2012-04-02       Impact factor: 7.327

9.  Realities of replication: implementation of evidence-based interventions for HIV prevention in real-world settings.

Authors:  Shayna D Cunningham; Josefina J Card
Journal:  Implement Sci       Date:  2014-01-06       Impact factor: 7.327

10.  Organizational culture and climate as moderators of enhanced outreach for persons with serious mental illness: results from a cluster-randomized trial of adaptive implementation strategies.

Authors:  Shawna N Smith; Daniel Almirall; Katherine Prenovost; David E Goodrich; Kristen M Abraham; Celeste Liebrecht; Amy M Kilbourne
Journal:  Implement Sci       Date:  2018-07-09       Impact factor: 7.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.